Delving into the Latest Updates on Yantai North Pharmaceutical Co., Ltd. with Synapse

Overview

1. 研究中国健康男性受试者交叉、单次、皮下注射国产注射用那屈肝素钙和原研药品那屈肝素钙注射液的药效动力学，评价二制剂间是否存在生物等效性。 2. 研究那屈肝素钙的药代动力学（抗Ⅹa因子活性PK，抗Ⅱa因子活性PK）。

[Translation]

1. To study the pharmacodynamics of domestic nadroparin calcium for injection and original nadroparin calcium injection in healthy Chinese male subjects after crossover, single, subcutaneous injection, and evaluate whether there is bioequivalence between the two preparations. 2. To study the pharmacokinetics of nadroparin calcium (anti-factor Xa activity PK, anti-factor IIa activity PK).

Start Date-

Sponsor / Collaborator

Yantai North Pharmaceutical Co., Ltd.

100 Clinical Results associated with Yantai North Pharmaceutical Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Yantai North Pharmaceutical Co., Ltd.

Login to view more data

100 Deals associated with Yantai North Pharmaceutical Co., Ltd.

Login to view more data

100 Translational Medicine associated with Yantai North Pharmaceutical Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 07 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Other

1

Login to view more data